Poste Italiane S.p.A. (0RC2)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 24.16 |
|---|---|
| 52-week range | 18.69 – 29.77 |
| Return, 1 month / 3 months | −10.5% / −12.4% |
| Return, 1 year / 3 years | +26.3% / +217.7% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 20.5% |
| Worst drawdown (1 year) | -18.4% |
| Average daily value traded | 10.80M EUR |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Poste Italiane is the Italian postal and logistics group, based in Rome. It delivers letters and parcels across Italy through its nationwide network of post offices and its mail and logistics operations. The company also offers financial and insurance services, including savings products, payments and cards, to households and small businesses, and it provides mobile and digital services. Its customers are mainly individuals, families and small enterprises in Italy, served through post offices and online channels.
On this site Poste Italiane S.p.A. appears as a stock on the London Exchange (UK), code 0RC2, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Poste Italiane S.p.A. (0RC2) trades on the London Exchange in UK. It last closed at EUR 24.16 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 603 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.3% and over the last three months it fell 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.3% | ||
| From 52-week high | -17.2% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.4% | ||
| 6-month return | 11.1% | ||
| 12-month return, skipping the last month | 41.1% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.4% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.80M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 86 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −10.5% |
| 3 months | −12.4% |
| 6 months | +11.1% |
| 1 year | +26.3% |
| 3 years | +217.7% |
| 5 years | +166.1% |
Signals
| 50-day / 200-day average | 25.99 / 24.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.55 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 0.8500 |
| 24 Nov 2025 | EUR 0.4000 |
| 23 Jun 2025 | EUR 0.7500 |
| 18 Nov 2024 | EUR 0.3300 |
| 24 Jun 2024 | EUR 0.5630 |
| 20 Nov 2023 | EUR 0.2370 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.